Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinbang Stem Cell Injection for Knee Osteoarthritis (Phase II)
CTR20254973Phase 2Active
- Sponsor
- Shandong Xingrui Biological Technology
- Start
- Dec 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Xinbang mesenchymal stem cell injection in knee osteoarthritis (OA), sponsored by Shandong Xingrui Biological Technology. Started Dec 2025; status: active.
02
Drugs
Xinbang mesenchymal stem cell injection
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20254973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254973.